KR870000066A - 비강 삽입제의 제조방법 - Google Patents

비강 삽입제의 제조방법 Download PDF

Info

Publication number
KR870000066A
KR870000066A KR1019860004329A KR860004329A KR870000066A KR 870000066 A KR870000066 A KR 870000066A KR 1019860004329 A KR1019860004329 A KR 1019860004329A KR 860004329 A KR860004329 A KR 860004329A KR 870000066 A KR870000066 A KR 870000066A
Authority
KR
South Korea
Prior art keywords
nasal insert
manufacturing
active agent
physiologically active
systematic activity
Prior art date
Application number
KR1019860004329A
Other languages
English (en)
Inventor
아즈리아 모아즈
Original Assignee
쟌 크라메르,한스 루돌프 하우스
산도즈 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쟌 크라메르,한스 루돌프 하우스, 산도즈 리미티드 filed Critical 쟌 크라메르,한스 루돌프 하우스
Publication of KR870000066A publication Critical patent/KR870000066A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

비강 삽입제의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. a) 계통적 활성을 갖는 생리학적 활성제제를 젤라틴 및 혹은 히드록시프로필 메틸셀룰로오즈로 구성된 다공성 매트릭스에 충분히 분산시키고
    6) 실온의 수용액에 스폰지를 침지시키는 방법으로 비강 삽입제에 캘시토닌을 완전히 분산시킨 뒤 용매를 증발시키는 것으로 구성된 계통적 활성을 갖는 생리학적 활성제제를 함유한 비강 삽입제의 제조방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019860004329A 1985-06-04 1986-06-02 비강 삽입제의 제조방법 KR870000066A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858514090A GB8514090D0 (en) 1985-06-04 1985-06-04 Organic compounds
GB8514090 1985-06-04

Publications (1)

Publication Number Publication Date
KR870000066A true KR870000066A (ko) 1987-02-16

Family

ID=10580163

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860004329A KR870000066A (ko) 1985-06-04 1986-06-02 비강 삽입제의 제조방법

Country Status (21)

Country Link
US (1) US4988512A (ko)
JP (1) JPS61282320A (ko)
KR (1) KR870000066A (ko)
AU (1) AU5824786A (ko)
BE (1) BE904863A (ko)
CH (1) CH668913A5 (ko)
DE (1) DE3617728A1 (ko)
DK (1) DK259186A (ko)
ES (1) ES8801130A1 (ko)
FR (1) FR2582511B1 (ko)
GB (3) GB8514090D0 (ko)
GR (1) GR861422B (ko)
HU (1) HU199300B (ko)
IL (1) IL78980A0 (ko)
IT (1) IT1214683B (ko)
LU (1) LU86457A1 (ko)
NL (1) NL8601285A (ko)
NZ (1) NZ216393A (ko)
PT (1) PT82691B (ko)
SE (1) SE8602530L (ko)
ZA (1) ZA864164B (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH657779A5 (de) * 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
DE3726517A1 (de) * 1986-08-18 1988-03-03 Sandoz Ag Nasale zusammensetzungen, welche octreotid enthalten
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
US5690954A (en) * 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
GB8712176D0 (en) * 1987-05-22 1987-06-24 Cosmas Damian Ltd Drug delivery system
GB8723846D0 (en) * 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
HU222249B1 (hu) * 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
DE4115849A1 (de) * 1991-05-15 1992-11-19 Lohmann Therapie Syst Lts Penetrationsfoerdernde substanz
AU669110B2 (en) * 1991-05-24 1996-05-30 Amylin Pharmaceuticals, Inc. Amylin and possibly insulin containing composition for the treatment of anorexia and related states
DE4140192C2 (de) * 1991-12-05 1996-02-29 Alfatec Pharma Gmbh Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen
AU3343093A (en) * 1992-01-17 1993-08-03 Alfatec-Pharma Gmbh Pellets containing peptide drugs, their manufacture and use
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
GB9623205D0 (en) * 1996-11-07 1997-01-08 Eurand Int Novel pharmaceutical compositions
DE69931354T2 (de) * 1998-02-13 2007-02-01 Bioniche Life Sciences Inc., Belleville Vorrichtung zum verabreichen eines medikamentes
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6759393B1 (en) 1999-04-12 2004-07-06 Pfizer Inc. Growth hormone and growth hormone releasing hormone compositions
WO2004084859A2 (en) * 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol
AU2005231738A1 (en) * 2004-03-26 2005-10-20 Katz, David F. Mr Bioresponsive polymer system for delivery of microbicides
US7396936B1 (en) 2004-11-09 2008-07-08 Kemia, Inc. Modulators of calcitonin and amylin receptor activity

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US820948A (en) * 1905-01-23 1906-05-22 Edward Baum Device fot treating the nasal passages.
US3234091A (en) * 1955-07-08 1966-02-08 Ciba Geigy Corp Shaped medicaments and process for their manufacture
DE1617564A1 (de) * 1966-12-03 1971-04-01 Rudolf Kisro Arzneimitteltraeger
DK135268A (ko) * 1973-02-09
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4164560A (en) * 1977-01-05 1979-08-14 Folkman Moses J Systems for the controlled release of macromolecules
US4391797A (en) * 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
JPS56100714A (en) * 1980-01-16 1981-08-12 Teijin Ltd Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane
JPS576403A (en) * 1980-06-12 1982-01-13 Toshiba Corp Recording and reproducing device
GB2090535B (en) * 1981-01-06 1984-09-19 Osman Mohammad Fekry Medical inserts
JPS5921613A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd 直腸投与製剤
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
FR2537980B1 (fr) * 1982-12-17 1986-12-19 Sandoz Sa Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4591496A (en) * 1984-01-16 1986-05-27 Massachusetts Institute Of Technology Process for making systems for the controlled release of macromolecules

Also Published As

Publication number Publication date
GB8613284D0 (en) 1986-07-09
GR861422B (en) 1986-10-01
HUT49288A (en) 1989-09-28
NL8601285A (nl) 1987-01-02
DK259186A (da) 1986-12-05
DE3617728A1 (de) 1986-12-04
AU5824786A (en) 1986-12-11
IL78980A0 (en) 1986-09-30
CH668913A5 (de) 1989-02-15
NZ216393A (en) 1989-08-29
FR2582511B1 (fr) 1989-05-26
FR2582511A1 (fr) 1986-12-05
IT1214683B (it) 1990-01-18
GB2176105A (en) 1986-12-17
JPS61282320A (ja) 1986-12-12
PT82691B (en) 1988-05-03
SE8602530L (sv) 1986-12-05
US4988512A (en) 1991-01-29
SE8602530D0 (sv) 1986-06-04
ES555676A0 (es) 1988-01-01
ZA864164B (en) 1988-01-27
DK259186D0 (da) 1986-06-02
IT8648098A0 (it) 1986-06-04
BE904863A (fr) 1986-12-03
GB2213377A (en) 1989-08-16
ES8801130A1 (es) 1988-01-01
GB8906584D0 (en) 1989-05-04
PT82691A (en) 1986-07-01
GB8514090D0 (en) 1985-07-10
GB2176105B (en) 1990-03-07
HU199300B (en) 1990-02-28
LU86457A1 (fr) 1987-01-13

Similar Documents

Publication Publication Date Title
KR870000066A (ko) 비강 삽입제의 제조방법
DE69102140T2 (de) Wirkstoffabgabevorrichtung die ein hydrophobisches mittel enthält.
ES2119011T3 (es) Catalizador que contiene platino y estaño y su uso en la deshidrogenacion de alcanos.
DK165046C (da) Anvendelse af n-acetylneuraminsyre eller et salt heraf til fremstilling af et ekspektorationsmiddel
ATE158177T1 (de) Sol-gesteuerte thermokolloidmatrix auf gelatine basis für perorale retardformen
KR900015719A (ko) 점안용 안압조정제
KR900000335A (ko) 히드록시알킬시스테인 유도체 및 이를 함유하는 거담제
KR910005850A (ko) 피부 외용제
KR870003688A (ko) 논에 사용하는 제초제의 제조방법
KR900018735A (ko) 할로겐화은 사진 감광 재료의 제조 및 보존방법
NO158984C (no) Anvendelse av (e)-beta-farnesen i vaeskeform eller av en (e)-beta-farnesen-inneholdende vaeske som et kontaktinsekticidmot bladlus.
ATE108326T1 (de) Wässerige desmopressin-cmc enthaltende arzneizubereitung.
KR890015438A (ko) 초전도 박막
KR870003788A (ko) 모발자극 화합물
KR880000094A (ko) 위염치료제
KR910018539A (ko) 도토리 또는 상수리분을 이용한 유색주의 제조방법
KR880000109A (ko) 내용 고형제(의약품)의 살균 저장방법
KR880000100A (ko) 안중산가 작약감초 겔(또는 졸)의 제조방법
KR940006599A (ko) 인삼 진세노사이드 Rb1을 함유하는 항 대사성 당뇨제
JPS62166201U (ko)
KR890007717A (ko) 약제 디스펜서
JPS5954501U (ja) 液状活性物質含有製剤
JPS5838758U (ja) 熱接着シ−ト
KR870002234A (ko) 인조목탄의 제조방법
KR880012237A (ko) 트롬빈 제제의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application